JOEL S MARCUS
CIK 1216955 · Executive Chairman · last filed 2026-05-07
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$51.03M
Companies
9
Total Filings
284
Lifetime Open-Market Net
-$156.07M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ARE | Executive Chairman | 587,724 | $53.17 | $31.25M | -$77.93M | 157 | 2026-05-07 |
| Intra-Cellular Therapies, Inc. (ITCI) Delisted | Director | 0 | $131.87 | $0 | -$13.07M | 43 | 2025-04-02 |
| Applied Therapeutics, Inc. (APLT) Delisted | Director | 565,849 | $0.10 | $58.3K | -$257.6K | 15 | 2024-06-07 |
| Korro Bio, Inc. (FREQ) Delisted | Director | 1,318,846 | $14.98 | $19.76M | -$1.32M | 11 | 2022-08-19 |
| MGTX | Director | 1,995,608 | $9.59 | $19.14M | -$294.2K | 7 | 2022-06-09 |
| ALEXANDRIA REAL ESTATE EQUITIES, INC. (AREpD) Delisted | Executive Chairman | 445,962 | — | — | -$61.81M | 36 | 2019-09-10 |
| ATRA | Director | 11,500 | $10.41 | $119.7K | -$1.52M | 12 | 2019-03-19 |
| REXR | Director | 12,858 | $35.09 | $451.2K | $140.0K | 1 | 2013-07-24 |
| PMT | Director | 7,000 | $10.12 | $70.8K | $0 | 2 | 2012-05-18 |
Recent Filings · Page 18 of 29
284 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2015-03-11 | ATRA | Buy (P) | +4,000 | $118.3K | EDGAR |
| 2015-03-09 | ARE | Sell (S) | −200 | -$19.6K | EDGAR |
| 2015-02-09 | ARE | Sell (S) | −15,000 | -$1.44M | EDGAR |
| 2015-01-21 | ATRA | Grant (A) | — | $0 | EDGAR |
| 2015-01-05 | Intra-Cellular Therapies, Inc. (ITCI) Delisted | Grant (A) | +609 | $0 | EDGAR |
| 2014-12-11 | ARE | Sell (S) | −4,000 | -$364.8K | EDGAR |
| 2014-11-12 | ARE | Sell (S) | −9,000 | -$749.8K | EDGAR |
| 2014-10-23 | ATRA | Mixed | +908,355 | $1.65M | EDGAR |
| 2014-10-02 | Intra-Cellular Therapies, Inc. (ITCI) Delisted | Grant (A) | +784 | $0 | EDGAR |
| 2014-08-18 | ARE | Sell (S) | −2,000 | -$156.8K | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.